79 related articles for article (PubMed ID: 36254139)
1. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract][Full Text] [Related]
2. Phylogenetic Analysis Guides Transporter Protein Deorphanization: A Case Study of the SLC25 Family of Mitochondrial Metabolite Transporters.
Byrne KL; Szeligowski RV; Shen H
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759714
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the link between lactate metabolism and rheumatoid arthritis through integration of bioinformatics and machine learning.
Yang F; Shen J; Zhao Z; Shang W; Cai H
Sci Rep; 2024 Apr; 14(1):9166. PubMed ID: 38644410
[TBL] [Abstract][Full Text] [Related]
4. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
5. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer.
Liu AR; Liu YN; Shen SX; Yan LR; Lv Z; Ding HX; Wang A; Yuan Y; Xu Q
Biomed Res Int; 2022; 2022():4009354. PubMed ID: 36254139
[TBL] [Abstract][Full Text] [Related]
7. An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.
Chen YJ; Hong WF; Liu ML; Guo X; Yu YY; Cui YH; Liu TS; Liang L
Cell Death Dis; 2022 Mar; 13(3):237. PubMed ID: 35288533
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy.
Rochette L; Meloux A; Zeller M; Malka G; Cottin Y; Vergely C
Molecules; 2020 May; 25(10):. PubMed ID: 32455902
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
10. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
12. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.
Yang H; Deng Q; Ni T; Liu Y; Lu L; Dai H; Wang H; Yang W
Int J Biol Sci; 2021; 17(15):4207-4222. PubMed ID: 34803493
[No Abstract] [Full Text] [Related]
13. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma.
Nie M; Yao K; Zhu X; Chen N; Xiao N; Wang Y; Peng B; Yao L; Li P; Zhang P; Hu Z
Nat Commun; 2021 Nov; 12(1):6479. PubMed ID: 34759281
[TBL] [Abstract][Full Text] [Related]
14. Heme catabolism by tumor-associated macrophages controls metastasis formation.
Consonni FM; Bleve A; Totaro MG; Storto M; Kunderfranco P; Termanini A; Pasqualini F; Alì C; Pandolfo C; Sgambelluri F; Grazia G; Santinami M; Maurichi A; Milione M; Erreni M; Doni A; Fabbri M; Gribaldo L; Rulli E; Soares MP; Torri V; Mortarini R; Anichini A; Sica A
Nat Immunol; 2021 May; 22(5):595-606. PubMed ID: 33903766
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
